IL117530A - Storage-stable drug forms - Google Patents

Storage-stable drug forms

Info

Publication number
IL117530A
IL117530A IL11753096A IL11753096A IL117530A IL 117530 A IL117530 A IL 117530A IL 11753096 A IL11753096 A IL 11753096A IL 11753096 A IL11753096 A IL 11753096A IL 117530 A IL117530 A IL 117530A
Authority
IL
Israel
Prior art keywords
pct
drug forms
storage
stable drug
date sep
Prior art date
Application number
IL11753096A
Other languages
English (en)
Other versions
IL117530A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL117530A0 publication Critical patent/IL117530A0/xx
Publication of IL117530A publication Critical patent/IL117530A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
IL11753096A 1995-03-21 1996-03-18 Storage-stable drug forms IL117530A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19509806A DE19509806A1 (de) 1995-03-21 1995-03-21 Lagerstabile Arzneiformen

Publications (2)

Publication Number Publication Date
IL117530A0 IL117530A0 (en) 1996-07-23
IL117530A true IL117530A (en) 1999-12-31

Family

ID=7757017

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11753096A IL117530A (en) 1995-03-21 1996-03-18 Storage-stable drug forms

Country Status (16)

Country Link
US (1) US5945127A (xx)
EP (1) EP0814781B1 (xx)
JP (1) JPH11502208A (xx)
AT (1) ATE213153T1 (xx)
AU (1) AU5105196A (xx)
BR (1) BR9607796A (xx)
CA (1) CA2213720A1 (xx)
DE (2) DE19509806A1 (xx)
DK (1) DK0814781T3 (xx)
ES (1) ES2172655T3 (xx)
HU (1) HUP9801151A3 (xx)
IL (1) IL117530A (xx)
NO (1) NO974337D0 (xx)
PT (1) PT814781E (xx)
WO (1) WO1996029060A1 (xx)
ZA (1) ZA962242B (xx)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602206A1 (de) 1996-01-23 1997-07-24 Basf Ag Zubereitungen nichtsteroidaler Analgetika
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
ATE400252T1 (de) * 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
JP5767429B2 (ja) * 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
BR0207297A (pt) * 2001-02-15 2005-04-19 King Pharmaceuticals Inc Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
WO2003034302A1 (fr) * 2001-10-15 2003-04-24 Stark Co., Ltd. Serveur de fourniture de contenu et systeme de fourniture de contenu dote d'un tel serveur
US20030180356A1 (en) * 2001-10-29 2003-09-25 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
RU2005103625A (ru) 2002-08-12 2005-08-20 Пфайзер Продактс Инк. (Us) Фармацевтические композиции полуупорядоченных лекарств и полимеров
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
AU2011224098B2 (en) * 2005-05-10 2013-10-31 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds
US20090023754A1 (en) * 2005-05-10 2009-01-22 Wai Yip Lee Modified release famciclovir pharmaceutical compositions
RU2405539C2 (ru) * 2005-05-10 2010-12-10 Новартис Аг Экструзионный способ приготовления композиций, содержащих плохо прессующиеся лекарственные соединения
US7666963B2 (en) * 2005-07-21 2010-02-23 Akzo Nobel N.V. Hybrid copolymers
WO2011014783A1 (en) 2009-07-31 2011-02-03 Akzo Nobel N.V. Hybrid copolymer compositions
NO20073821L (no) * 2006-07-21 2008-01-22 Akzo Nobel Chemicals Int Bv Podede kopolymerer med lav molekylvekt
US8674021B2 (en) 2006-07-21 2014-03-18 Akzo Nobel N.V. Sulfonated graft copolymers
WO2008067164A2 (en) * 2006-11-15 2008-06-05 Abbott Laboratories Solid pharmaceutical dosage formulations
MX2009013683A (es) * 2007-06-13 2010-04-07 Jay Pravda Materiales y metodos para el tratamiento y diagnostico de trastornos asociados con estres oxidativo.
US8613834B2 (en) 2008-04-03 2013-12-24 Basf Se Paper coating or binding formulations and methods of making and using same
US8636918B2 (en) 2011-08-05 2014-01-28 Ecolab Usa Inc. Cleaning composition containing a polysaccharide hybrid polymer composition and methods of controlling hard water scale
US8853144B2 (en) 2011-08-05 2014-10-07 Ecolab Usa Inc. Cleaning composition containing a polysaccharide graft polymer composition and methods of improving drainage
US8679366B2 (en) 2011-08-05 2014-03-25 Ecolab Usa Inc. Cleaning composition containing a polysaccharide graft polymer composition and methods of controlling hard water scale
US8841246B2 (en) 2011-08-05 2014-09-23 Ecolab Usa Inc. Cleaning composition containing a polysaccharide hybrid polymer composition and methods of improving drainage
MX2014005089A (es) 2011-11-04 2014-08-08 Akzo Nobel Chemicals Int Bv Copolimeros de dendrita de injerto, y metodos para producir los mismos.
EP2773320B1 (en) 2011-11-04 2016-02-03 Akzo Nobel Chemicals International B.V. Hybrid dendrite copolymers, compositions thereof and methods for producing the same
US9687010B2 (en) * 2012-03-14 2017-06-27 Mccormick & Company, Incorporated Extrusion encapsulation of actives at an increased load, using surface active plant extracts
US8945314B2 (en) 2012-07-30 2015-02-03 Ecolab Usa Inc. Biodegradable stability binding agent for a solid detergent
US8809308B2 (en) 2012-11-09 2014-08-19 Scidose, Llc Enema composition for treatment of ulcerative colitis having long term stability
US9365805B2 (en) 2014-05-15 2016-06-14 Ecolab Usa Inc. Bio-based pot and pan pre-soak

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520180A (en) * 1982-09-20 1985-05-28 Gaf Corporation Polymerization of vinylpyrrolidone to various molecular weights using a single initiator system consisting essentially of t-Butylperoxypivalate
US4712460A (en) * 1985-11-18 1987-12-15 Biotrack, Inc. Integrated drug dosage form and metering system
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen

Also Published As

Publication number Publication date
CA2213720A1 (en) 1996-09-26
PT814781E (pt) 2002-07-31
ZA962242B (en) 1997-09-22
NO974337L (no) 1997-09-19
DE19509806A1 (de) 1996-09-26
BR9607796A (pt) 1998-07-07
NO974337D0 (no) 1997-09-19
ES2172655T3 (es) 2002-10-01
EP0814781A1 (de) 1998-01-07
JPH11502208A (ja) 1999-02-23
EP0814781B1 (de) 2002-02-13
IL117530A0 (en) 1996-07-23
US5945127A (en) 1999-08-31
WO1996029060A1 (de) 1996-09-26
DE59608732D1 (de) 2002-03-21
DK0814781T3 (da) 2002-03-18
AU5105196A (en) 1996-10-08
HUP9801151A3 (en) 2000-06-28
HUP9801151A2 (hu) 1998-08-28
ATE213153T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
IL117530A0 (en) Storage-stable drug forms
AU4786096A (en) Solid active agent preparations
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
AU5106996A (en) Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby
ATE293458T1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
DE69727922D1 (de) Schnell zerfallende orale dosierungsform
AU7362496A (en) Dimer-selective rxr modulators and methods for their use
FI95768C (fi) Emättimensisäinen antosysteemi
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
GB9515279D0 (en) Improved therapeutic agents
GEP20063719B (en) Prevention of Migraine Recurrence
ATE173399T1 (de) Retardtablette mit einem gehalt an diclofenac-na
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
RS49520B (sr) Antimikrobno aktivne smeše
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
AU5690496A (en) Polyketone polymer composition
AU5696194A (en) Methylbutoxy-propionitriles and their use as perfumes
FR2696066B1 (fr) Procédé pour transmettre des messages, et unité fonctionnelle et installation s'y rapportant.
UA23119A (uk) Психотропhий засіб

Legal Events

Date Code Title Description
FF Patent granted